Granulocyte-colony stimulating factor (G-CSF) therapy in antithyroid drug-induced agranulocytosis

Endocrine Journal

Volumn 52, Issue 3, 2005, Pages 383-

  Andrès, Emmanuel ^a   Maloisel, Frédéric ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

AGRANULOCYTOSIS; BLOOD CELL COUNT; BLOOD TOXICITY; DRUG INDUCED DISEASE; HUMAN; LETTER; SIDE EFFECT; THYROID DISEASE;

AGRANULOCYTOSIS; ANTITHYROID AGENTS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS;

EID: 22344435512     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.52.383     Document Type: Letter

References (5)

1. Murakami Y, Sasaki I, Hiraiwa T, Arishima T, Ito M, Hanafusa T, Sakane S, Ohsawa N, Takamatsu J, Miyauchi A, Kuma K (2004) Serum concentration of Granulocyte Colony Stimulating Factor (G-CSF) in antithyroid drug-induced agranulocytosis. Endocr J 51: 579-583.
2. Andrès E, Kurtz JE, Maloisel F (2002) Non-chemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. Clin Lab Haematol 24: 99-106.
3. Tajiri J (2005) Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid 15: 292-297.
4. Andrès E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F (2001) The use of haematopoietic growth factors in antithyroid-related drug-induced agranulocytosis: a report of 20 patients. QJM 94: 423-428.
5. Fukata S, Kuma K, Sugawara M (1999) Granulocyte-colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid 9: 29-31.